Allspring Global Investments’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.3M Sell
765,120
-125,104
-14% -$8.04M 0.09% 257
2026
Q1
$50.1M Sell
890,224
-49,503
-5% -$3.22M 0.08% 284
2025
Q4
$75.2M Sell
939,727
-121,063
-11% -$8.13M 0.12% 206
2025
Q3
$51.8M Buy
1,060,790
+111,307
+12% +$6.89M 0.08% 279
2025
Q2
$72.5M Sell
949,483
-16,684
-2% -$1.1M 0.12% 211
2025
Q1
$60.9M Buy
966,167
+165,118
+21% +$11.2M 0.11% 241
2024
Q4
$62.8M Buy
801,049
+5,668
+0.7% +$455K 0.1% 240
2024
Q3
$63.9M Buy
795,381
+343,214
+76% +$27.7M 0.1% 254
2024
Q2
$37.4M Sell
452,167
-50,826
-10% -$4.47M 0.06% 374
2024
Q1
$42.9M Buy
502,993
+286,897
+133% +$22.5M 0.07% 372
2023
Q4
$18.5M Sell
216,096
-4,209
-2% -$364K 0.03% 573
2023
Q3
$19.7M Sell
220,305
-3,697
-2% -$330K 0.04% 560
2023
Q2
$19.1M Sell
224,002
-78,177
-26% -$6.61M 0.03% 606
2023
Q1
$25M Sell
302,179
-17,408
-5% -$1.41M 0.04% 525
2022
Q4
$25.1M Sell
319,587
-23,750
-7% -$1.91M 0.04% 509
2022
Q3
$25.4M Sell
343,337
-30,880
-8% -$2.22M 0.05% 498
2022
Q2
$24.4M Buy
374,217
+41,044
+12% +$2.43M 0.04% 521
2022
Q1
$21.1M Sell
333,173
-7,270
-2% -$395K 0.03% 651
2021
Q4
$18.1M Buy
+340,443
New +$20.7M 0.02% 735

Other funds holding HAE

Allspring Global Investments's HAE Position: Q2 2026 in Review

Allspring Global Investments reduced its Haemonetics (HAE) stake by 14% in Q2 2026, selling an estimated $8.04M and leaving 765,120 shares worth $57.3M. The position accounts for 0.09% of the portfolio, ranked #257.

Allspring Global Investments first reported a position in HAE in Q4 2021 and has held it in 19 quarters since. The position peaked at $75.2M in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Allspring Global Investments held 765,120 shares of Haemonetics worth $57.3M as of Q2 2026.
  • Allspring Global Investments sold 125,104 Haemonetics shares in Q2 2026, an estimated $8.04M.
  • Haemonetics made up 0.09% of Allspring Global Investments's portfolio in Q2 2026, its #257 holding.
  • Allspring Global Investments first reported a position in Haemonetics in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Haemonetics position peaked at $75.2M in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.